Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 3 Device Recall DIFCO BACTO FA Streptococcus Group A

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 3 Device Recall DIFCO BACTO FA Streptococcus Group A see related information
Date Initiated by Firm August 08, 2007
Date Posted September 11, 2008
Recall Status1 Terminated 3 on March 24, 2009
Recall Number Z-1319-2008
Recall Event ID 46759
Product Classification in vitro diagnostic - Product Code GTQ
Product DIFCO Laboratories, FA Streptococcus Group A, 5mL, Catalog Number: 223181, Lot number: 6122656, Exp: 20090705, in vitro diagnostic.
Code Information Catalog number: 223181, Lot number: 6122656, Exp: 20090705.
Recalling Firm/
Manufacturer		 BD Diagnostic Systems / Lee Laboratories
1475 Athens Hwy
Grayson GA 30017-1538
For Additional Information Contact Steve J. Strouphauer
678-259-2585
Manufacturer Reason
for Recall		 Incorrect result: The product exhibited decreased fluorescence when testing with the homologous control organism.
FDA Determined
Cause 2		 Nonconforming Material/Component
Action Becton Dickinson (BD) Diagnostic Systems sent an Urgent product recall letter, dated August 2007, to all consignees, directing them to discard this lot of product. BD instructed distributors to discontinue distribution and discard any remaining product in inventory. BD requested the distributors provide an Excel file or a customer list containing the name, address and telephone number of end-users who were shipped the product. BD provided alternative testing methods. A response form was included to verify receipt of notification.
Quantity in Commerce 26 units
Distribution Nationwide Distribution and Canada
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-